Recombinant Human gABRb1 Protein，His

GABAB receptors, particularly the GABAB1 subunit, play a crucial role in the central nervous system by mediating inhibitory neurotransmission through the binding of the neurotransmitter gamma-aminobutyric acid (GABA). These metabotropic receptors are implicated in a wide range of physiological processes, including mood regulation, pain modulation, and learning and memory. Given their significant involvement in various neurological disorders, such as epilepsy, anxiety, and schizophrenia, there has been increasing interest in the study of GABAB1 as a potential therapeutic target. The research into recombinant GABAB1 protein facilitates the understanding of its structure, function, and interactions with other proteins, which is essential for drug discovery and the development of novel pharmacological strategies. Advances in recombinant DNA technology have enabled the production of functional GABAB1 proteins, allowing scientists to investigate their pharmacological properties, signaling mechanisms, and the effects of ligands. This research holds promise for uncovering new approaches to modulate GABAB receptor activity, thereby contributing to the treatment of various neuropsychiatric diseases. Furthermore, the exploration of GABAB1's role in receptor heterodimerization with its partner subunit GABAB2 enhances our comprehension of the receptor's overall functionality and its therapeutic potential.